Associate Provost for Research
Boston University Medical Campus
NICHD - National Institute of Child Health & Human Development Research Resources

Abstract

Grant Number: 1R21HD055814-01
PI Name: ANDERSON, DEBORAH J.
PI Email: deborah.anderson@bmc.org
PI Title: PROFESSOR
Project Title: An In Vitro Model of Cell-Associated HIV-1 Transmission

Abstract: DESCRIPTION (provided by applicant): The long-term objectives of this project are to define molecular events underlying cell-associated (CA) HIV-1 transmission across human cervical and vaginal epithelia, and to develop an in vitro model for testing the effects of vaginal microbicide formulations on CA HIV-1 transmission. The aims of the first (R21) phase of this project are to define adhesion molecule receptor/ligand combinations that play a role in the attachment of HIV-1 infected cells to human cervicovaginal epithelial cells, and chemokine/ chemokine receptor (CR) combinations that promote penetration of infected cells into the vaginal epithelium. We will use multichannel cytofluorometric analysis to characterize adhesion molecule and chemokine receptor (CR) expression on CD4+ lymphocytes and macrophages isolated from semen of HIV-infected men, and immunohistochemistry and Bio-Plex/ELISA assays to characterize the expression of complementary adhesion molecules and chemokines by cells in human vaginal and cervical tissues. We will perform parallel studies on CD4+ lymphocyte and macrophage cell lines (HIV+ seminal cell surrogates) and on the MatTek EpiVag organotypic model (human vaginal epithelium surrogate) to validate their appropriate expression of these molecules as the first step towards establishing an authentic in vitro model of CA HIV-1 sexual transmission. In Phase II (R33) we will use the MatTek EpiVag model to further define mechanisms of CA HIV vaginal transmission, and to develop and validate a quantitative CA HIV transmission assay. We will use this assay to test the efficacy of vaginal microbicide formulations and to screen for other factors that inhibit CA HIV transmission. This model system could accelerate the development of vaginal microbicides to prevent the sexual transmission of HIV-1, and lead to the identification of novel CA HIV blocking factors that could enhance the efficacy of vaginal microbicides.

Thesaurus Terms:
HIV infection, cervix, chemokine receptor, communicable disease transmission, selectin, vagina, virus cytopathogenic effect, virus infection mechanism
cytokine, helper T lymphocyte, hormone regulation /control mechanism, macrophage, model design /development, semen, sex partner, virus genetics, women's health
clinical research, enzyme linked immunosorbent assay, fluorimetry, gene expression profiling, human subject, immunocytochemistry, tissue /cell culture

Institution: BOSTON UNIVERSITY MEDICAL CAMPUS
715 ALBANY ST, 560
BOSTON, MA 021182394
Fiscal Year: 2006
Department: ENVIRONMENTAL HEALTH
Project Start: 30-SEP-2006
Project End: 31-AUG-2011
ICD: NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT
IRG: ZAI1


Boston, Tue, 23 Jan 2007 17:59:27 EST